Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Pheon Therapeutics
Merck Sharp & Dohme LLC
Tagworks Pharmaceuticals BV
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Iovance Biotherapeutics, Inc.
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
University of Alabama at Birmingham
AstraZeneca
Mayo Clinic
Curtin University
Providence Health & Services
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Novartis
Pfizer
Pfizer
AstraZeneca
Turning Point Therapeutics, Inc.
NRG Oncology
Taiho Oncology, Inc.
NRG Oncology
Alterome Therapeutics, Inc.
NRG Oncology
Boston Scientific Corporation
Peking University People's Hospital
Melanoma and Skin Cancer Trials Limited
Boston Scientific Corporation
SillaJen, Inc.
Eastern Cooperative Oncology Group
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center